Your browser doesn't support javascript.
loading
Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways.
Al-Tamimi, Maha; Khan, Abdul Q; Anver, Rasheeda; Ahmad, Fareed; M Mateo, Jericha; Raza, Syed Shadab; Alam, Majid; Buddenkotte, Joerg; Steinhoff, Martin; Uddin, Shahab.
Affiliation
  • Al-Tamimi M; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Khan AQ; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar. Electronic address: Akhan42@hamad.qa.
  • Anver R; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Ahmad F; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, Doha 3050, Qatar.
  • M Mateo J; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Raza SS; Department of Stem Cell Biology and Regenerative Medicine, Era University, Lucknow 226003, India.
  • Alam M; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, Doha 3050, Qatar.
  • Buddenkotte J; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, Doha 3050, Qatar.
  • Steinhoff M; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Department of Dermatology and Venereology, Rumailah Hospital, Hamad Medical Corporation, Doha 3050, Qatar; Dep
  • Uddin S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Dermatology Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar; Laboratory Animal Research Center, Qatar University, Doha, Qatar. Electronic address: Skhan34@hamad.qa.
Biomed Pharmacother ; 156: 113950, 2022 Dec.
Article de En | MEDLINE | ID: mdl-36411635
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Carcinome épidermoïde Limites: Humans Langue: En Journal: Biomed Pharmacother Année: 2022 Type de document: Article Pays d'affiliation: Qatar Pays de publication: France
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Carcinome épidermoïde Limites: Humans Langue: En Journal: Biomed Pharmacother Année: 2022 Type de document: Article Pays d'affiliation: Qatar Pays de publication: France